Anni Ahonen-Bishopp

Anni Ahonen-Bishopp

Auto-generated profile, based on publicly available information

Anni Ahonen-Bishopp

Biocomputing Platforms, Ltd, Espoo, Finland

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2011 in Journal of Cell Biology
Verified
Journal Article
Open access
MBMaxim M. Bespalov
Maxim M. Bespalov
Yulia SidorovaYulia Sidorova
Yulia Sidorova
STSarka Tumova
Sarka Tumova
AAAnni Ahonen-Bishopp
Anni Ahonen-Bishopp
AMAna Cathia Magalhães
Ana Cathia Magalhães
Mart SaarmaMart Saarma
Mart Saarma
Glial cell line–derived neurotrophic factor (GDNF) family ligands (GFLs) are potent survival factors for dopaminergic neurons and motoneurons with therapeutic potential for Parkinson’s disease. Soluble GFLs bind to a ligand-specific glycosylphosphatidylinositol-anchored coreceptor (GDNF family receptor α) and signal through the receptor tyrosine kinase RET. In this paper, we show that all immobilized matrix-bound GFLs, except persephin, use a fundamentally different receptor. They interact with syndecan-3, a transmembrane heparan sulfate (HS) proteoglycan, by binding to its HS chains with high affinity. GFL–syndecan-3 interaction mediates both cell spreading and neurite outgrowth with the involvement of Src kinase activation. GDNF promotes migration of cortical neurons in a syndecan-3–dependent manner, and in agreement, mice lacking syndecan-3 or GDNF have a reduced number of cortical γ-aminobutyric acid–releasing neurons, suggesting a central role for the two molecules in cortical development. Collectively, syndecan-3 may directly transduce GFL signals or serve as a coreceptor, presenting GFLs to the signaling receptor RET.

3 October 2012 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
MBMyles Byrne
Myles Byrne
IFIvo Fac Fokkema
Ivo Fac Fokkema
OLOwen Lancaster
Owen Lancaster
TATomasz Adamusiak
Tomasz Adamusiak
AAAnni Ahonen-Bishopp
Anni Ahonen-Bishopp
JMJuha Muilu
Juha Muilu
Background: Sharing of data about variation and the associated phenotypes is a critical need, yet variant information can be arbitrarily complex, making a single standard vocabulary elusive and re-formatting difficult. Complex standards have proven too time-consuming to implement. Results: The GEN2PHEN project addressed these difficulties by developing a comprehensive data model for capturing biomedical observations, Observ-OM, and building the VarioML format around it. VarioML pairs a simplified open specification for describing variants, with a toolkit for adapting the specification into one's own research workflow. Straightforward variant data can be captured, federated, and exchanged with no overhead; more complex data can be described, without loss of compatibility. The open specification enables push-button submission to gene variant databases (LSDBs) e.g., the Leiden Open Variation Database, using the Cafe Variome data publishing service, while VarioML bidirectionally transforms data between XML and web-application code formats, opening up new possibilities for open source web applications building on shared data. A Java implementation toolkit makes VarioML easily integrated into biomedical applications. VarioML is designed primarily for LSDB data submission and transfer scenarios, but can also be used as a standard variation data format for JSON and XML document databases and user interface components. Conclusions: VarioML is a set of tools and practices improving the availability, quality, and comprehensibility of human variation information. It enables researchers, diagnostic laboratories, and clinics to share that information with ease, clarity, and without ambiguity.